These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 6984337

  • 1. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [Abstract] [Full Text] [Related]

  • 2. Characteristic immunological responses to an experimental mouse brain tumor.
    Yamasaki T, Handa H, Yamashita J, Namba Y, Hanaoka M.
    Cancer Res; 1983 Oct; 43(10):4610-7. PubMed ID: 6603902
    [Abstract] [Full Text] [Related]

  • 3. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [Abstract] [Full Text] [Related]

  • 4. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
    [Abstract] [Full Text] [Related]

  • 5. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T, Yamashita J, Handa H, Namda Y, Hanaoka M.
    No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 7. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulatory effects of interleukin 2 and interferon on syngeneic murine malignant glioma-specific cytotoxic T-lymphocytes.
    Yamasaki T, Kikuchi H, Yamashita J, Handa H, Kuwata S, Taguchi M, Namba Y, Hanaoka M.
    Cancer Res; 1988 Jun 01; 48(11):2981-7. PubMed ID: 3259157
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH, Currie D, Hwang KM.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S, Fujiwara H, Yamane Y, Sano S, Nakajima H, Izumi Y, Arai H, Kawanishi Y, Tsuchida T, Hamaoka T.
    Jpn J Cancer Res; 1986 Feb 01; 77(2):182-9. PubMed ID: 3082830
    [Abstract] [Full Text] [Related]

  • 11. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
    Otsuka S, Suda K, Yamashita J, Takeuchi J, Handa H.
    No To Shinkei; 1982 Apr 01; 34(4):393-8. PubMed ID: 7093076
    [Abstract] [Full Text] [Related]

  • 12. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
    Yamamoto H, Takata M, Fujimoto S.
    Jpn J Cancer Res; 1987 Feb 01; 78(2):176-84. PubMed ID: 2951356
    [Abstract] [Full Text] [Related]

  • 13. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP, Cobbold SP, Waldmann H, Aguet M, Zinkernagel RM.
    J Immunol; 1987 Apr 01; 138(7):2278-81. PubMed ID: 2435794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas.
    Yamasaki T, Handa H, Yamashita J, Namba Y, Hanaoka M.
    J Neurooncol; 1986 Apr 01; 3(4):353-62. PubMed ID: 2937888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
    Plautz GE, Touhalisky JE, Shu S.
    Cell Immunol; 1997 Jun 15; 178(2):101-7. PubMed ID: 9225000
    [Abstract] [Full Text] [Related]

  • 18. Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.
    Paul RD, Lopez DM.
    Cancer Res; 1987 Feb 15; 47(4):1105-10. PubMed ID: 2879623
    [Abstract] [Full Text] [Related]

  • 19. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

  • 20. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E, Nouza K.
    Neoplasma; 1993 Feb 15; 40(2):75-80. PubMed ID: 8350958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.